Uscom Limited (ASX:UCM)

Market Cap	6.26M
Revenue (ttm)	3.63M
Net Income (ttm)	-2.36M
Shares Out	250.48M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,927
Average Volume	47,050
Open	0.0250
Previous Close	0.0250
Day's Range	0.0250 - 0.0250
52-Week Range	0.0110 - 0.0450
Beta	-1.21
RSI	49.49
Earnings Date	May 26, 2025

About Uscom

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 35
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: UCM

Financial Performance

In 2024, Uscom's revenue was 3.73 million, an increase of 39.89% compared to the previous year's 2.66 million. Losses were -2.07 million, -19.92% less than in 2023.